SCHEMBL6714650

SCHEMBL6714650

CCOC(=O)C(Cc1cccc(C(F)(F)F)c1)C(=O)OCC

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HTR2A P28223 3/20 0.55
HTR2B P41595 3/20 0.55
HTR2C P28335 2/20 0.55
THRB P10828 1/20 0.54
ADRA2C P18825 2/20 0.52
SLC6A4 P31645 2/20 0.52
ADRA1A P35348 2/20 0.52
DRD3 P35462 2/20 0.52
MAPT P10636 2/20 0.52
SIGMAR1 Q99720 1/20 0.52
LMNA P02545 1/20 0.52
OPRK1 P41145 1/20 0.52
USP2 O75604 2/20 0.51
CYP3A4 P08684 2/20 0.51
NR1I2 O75469 1/20 0.51
ADRB1 P08588 1/20 0.51
HTR1A P08908 1/20 0.51
ADRA2A P08913 1/20 0.51
ADORA3 P0DMS8 1/20 0.51
ADRA2B P18089 1/20 0.51

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30589450 1.00 HTR2A (0.55) HTR2AHTR2BHTR2CTHRBADRA2C
SCHEMBL4436742 0.93 HTR2A (0.51) HTR2AHTR2BHTR2CTHRBADRA2C
SCHEMBL16571756 0.92 HTR2A (0.50) HTR2AHTR2BHTR2CTHRBADRA2C
SCHEMBL15262748 0.91 THRB (0.49) HTR2AHTR2BHTR2CTHRBADRA2C
SCHEMBL15262515 0.88 ALDH1A1 (0.50) HTR2AHTR2BHTR2CTHRBADRA2C
SCHEMBL28017508 0.87 HTR2A (0.56) HTR2AHTR2BHTR2CTHRBADRA2C
SCHEMBL5752663 0.87 MDM2 (0.60) HTR2AHTR2BHTR2CTHRBADRA2C
SCHEMBL23125015 0.86 HTR2A (0.52) HTR2AHTR2BHTR2CTHRBADRA2C
SCHEMBL4140871 0.86 HTR2A (0.52) HTR2AHTR2BHTR2CTHRBADRA2C
SCHEMBL20543990 0.86 HTR2A (0.60) HTR2AHTR2BHTR2CTHRBADRA2C

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250027130-A1 Nucleic Acid Synthesis and Sequencing Using Tethered Nucleoside Triphosphates THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2025-01-23 US disclosed
WO-2023164676-A1 METHODS TO GENERATE NOVEL ACYL-TRNA SPECIES THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2023-08-31 WO disclosed
CN-102079697-A Preparation method of aryl propionic acid derivative SINOCHEM GROUP CO LTD 2011-06-01 CN disclosed
US-20040063729-A1 Microbiocides BAYER CROPSCIENCE K. K. (JP) 2004-04-01 US disclosed
EP-1345940-A2 TRIAZOLOPYRIMIDINES Bayer CropScience K.K. (JP) 2003-09-24 EP disclosed
WO-2002051845-A2 TRIAZOLOPYRIMIDINES BAYER CROPSCIENCE K.K. (DE) 2002-07-04 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040063729-A1 Microbiocides FPR1, MPO, FPR2 HTR2A 3157/4885HTR2B 2652/4885HTR2C 2720/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.